Explore the full management transaction log of Talkspace, Inc., a listed issuer based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Talkspace, Inc. has published 59 public disclosures. The latest transaction was filed on 10 June 2022 — Attribution. Among the most active insiders: Reilly John Charles. All data is free.
FY ended December 2025 · cache
25 of 59 declarations
Talkspace, Inc. is a U.S.-based digital health company focused on virtual behavioral healthcare. The company is listed on the NASDAQ market in the United States under the ticker TALK. Founded in 2012 and headquartered in New York, Talkspace built its early brand around a differentiated concept: enabling people to message with a licensed therapist anytime, from anywhere. That message-based therapy model later expanded into a broader virtual mental health offering, positioning the company as one of the best-known brands in online behavioral care. ([investors.talkspace.com](https://investors.talkspace.com/)) From an operating perspective, Talkspace runs a multi-line platform that spans individual therapy, couples therapy, teen therapy, psychiatry, and medication management for adults. Care can be delivered through live video, audio, live chat, or asynchronous messaging, all within an encrypted web and mobile platform designed to meet HIPAA and federal and state regulatory requirements. The company also offers self-guided tools and resources, giving it a broader product set than a pure therapy marketplace. Management states that its network includes 5,000+ licensed clinicians with expertise across more than 150 conditions and treatment modalities. ([investors.talkspace.com](https://investors.talkspace.com/)) Talkspace’s competitive position is anchored in network scale, payer relationships, and enterprise distribution. The company says it reaches more than 130 million covered lives through health plans, employee benefits programs, and business partnerships. It also describes itself as the largest in-network provider of virtual mental health therapy in the United States, a claim that matters in a market where competitors include telehealth specialists, broader digital health platforms, and payer-led behavioral health initiatives. For investors, the key question is not only user acquisition, but also reimbursement quality, clinician supply, retention, and the company’s ability to shift mix toward higher-quality institutional channels. ([investors.talkspace.com](https://investors.talkspace.com/)) Recent developments have been materially important. In its February 2026 full-year 2025 results, Talkspace reported 2025 revenue of $228.9 million, up 22% year over year, and guided for 2026 revenue of $275 million to $290 million with adjusted EBITDA of $30 million to $35 million. Management highlighted continued expansion in payer revenue and improving operating leverage, while consumer revenue remained weaker. In March 2026, Talkspace also announced that Universal Health Services would acquire the company, making this a major strategic and valuation event for shareholders. ([investors.talkspace.com](https://investors.talkspace.com/node/10196/pdf))